MELISSA L ZOOK

Allopathic & Osteopathic Physicians|Family Medicine LONDON, KY NPI 1467437293

General Payments — all program years on this page

$1,114.32

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 56
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $303.68 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $303.6816

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $65.804
Amgen Inc. $55.763
Lilly USA, LLC $55.343
Axsome Therapeutics, Inc. $32.811
Seqirus USA Inc $30.521
Merck Sharp & Dohme Corporation $28.542
ABBVIE INC. $18.821
GlaxoSmithKline, LLC. $16.091

By program year

Program yearAmountRecords
2018 $156.4912
2019 $115.418
2020 $85.881
2022 $116.695
2023 $336.1714
2024 $303.6816

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096897943 Novo Nordisk Inc $13.52 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097032733 Novo Nordisk Inc $14.73 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097276970 Novo Nordisk Inc $17.09 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097707124 Novo Nordisk Inc $20.46 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106400651 ABBVIE INC. $18.82 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116107740 GlaxoSmithKline, LLC. $16.09 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116225235 Amgen Inc. $16.50 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117423072 Amgen Inc. $20.27 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117423074 Amgen Inc. $18.99 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125629662 Seqirus USA Inc $30.52 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135188771 Lilly USA, LLC $18.68 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135213018 Lilly USA, LLC $16.85 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135213022 Lilly USA, LLC $19.81 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141733689 Merck Sharp & Dohme LLC $14.97 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141881716 Merck Sharp & Dohme LLC $13.57 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148304070 Axsome Therapeutics, Inc. $32.81 12/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.